Browse > Article
http://dx.doi.org/10.4062/biomolther.2009.17.2.181

Characterization of Plasma Carnitine Level in Obese Adolescent Korean Women  

Yoo, Hye-Hyun (Bioanalysis & Biotransformation Research Center, Korea Institute of Science and Technology)
Yoon, Ho-Joo (Department of Internal Medicine, College of Medicine, Hanyang University)
Shin, Hye-Jung (Department of Health Promotion Center, National Medical Center)
Lee, Sang-Hyup (Department of Biomedical & Analytical Chemistry, College of Pharmacy, Duksung Women's University)
Yoon, Hye-Ran (Department of Biomedical & Analytical Chemistry, College of Pharmacy, Duksung Women's University)
Publication Information
Biomolecules & Therapeutics / v.17, no.2, 2009 , pp. 181-187 More about this Journal
Abstract
Carnitine is known to be involved in lipid metabolism and affects body composition as well as energy metabolism of the whole body. Improvement of obesity by L-carnitine supplement suggests that obesity can be related with the abnormality of carnitine metabolism and therefore, plasma carnitine level in normal and obesity groups was investigated. For the characterization of plasma carnitine level in obese people, 60 plasma samples collected from Korean women subjects were analyzed using LC/MS and plasma fatty acid level was also determined using GC/MS. Additionally, several clinical chemical parameters including fasting glucose, cholesterol, AST, and ALT level were measured. All the data obtained were combined and pattern recognition analysis was carried out with the dataset. Obese group showed a different metabolic pattern compared with normal group. Plasma acylcarnitine level of the obese group was found to be $11.7{\mu}g/ml$, which was higher than that of normal group ($8.0{\mu}g/ml$). Statistically significant differences in plasma fatty acid level were not observed between the two groups. Other clinical parameters for the obese group were within normal ranges but AST and ALT levels were slightly elevated compared to normal group. The obese group showed elevated plasma acylcarnitine level.
Keywords
Carnitine; Obesity; LC/MS; GC/MS; Metabonomics;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
Times Cited By Web Of Science : 1  (Related Records In Web of Science)
Times Cited By SCOPUS : 1
연도 인용수 순위
1 Bonnefont, J. P., Demaugre, F., Prip-Buus, C., Saudubray, J. M., Brivet, M., Abadi, N. and Thuillier, L. (1999). Carnitine palmitoyltransferase deficiencies. Mol. Genet. Metab. 68, 424-440   DOI   ScienceOn
2 Broekhuysen, J., Baudine, A. and Deltour, G. (1965). Effect of carnitine on acidosis and ketosis induced by lipid perfusions in dogs during starvation. Biochim. Biophys. Acta 106, 207-210   DOI   ScienceOn
3 Ibrahim, W. H., Bailey, N., Sunvold, G. D. and Bruckner, G. G. (2003). Effects of carnitine and taurin on fatty acid metabolism and lipid accumulation in the liver of cats during weight gain and weight loss. Am. J. Vet. Res. 64, 1265-1277   DOI   ScienceOn
4 Longo, N., Amat di San Filippo, C. and Pasquali, M. (2006). Disorders of carnitine transport and the carnitine cycle. Am. J. Med. Genet. C Semin. Med. Genet. 142C, 77-85   DOI   ScienceOn
5 McGarry, J. D. and Brown, N. F. (1997). The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis. Eur. J. Biochem. 244, 1-14   DOI   ScienceOn
6 Minkler, P. E., Kerner, J., North, K. N. and Hoppel, C. L. (2005). Quantitation of long-chain acylcarnitines by HPLC/fluorescence detection: application to plasma and tissue specimens from patients with carnitine palmitoyltransferase-II deficiency. Clin. Chim. Acta 352, 81-92   DOI   ScienceOn
7 Quiros-Tejeira, R. E., Rivera, C. A., Ziba, T. T., Mehta, N., Smith, C. W. and Butte, N. F. (2007). Risk for nonalcoholic fatty liver disease in Hispanic youth with BMI $>$or =95th percentile. J. Pediatr. Gastroenterol Nutr. 44, 228-236   DOI   ScienceOn
8 Wutzke, K. D. and Lorenz, H. (2004). The effect of l-carnitine on fat oxidation, protein turnover, and body composition in slightly overweight subjects. Metabolism 53, 1002-1006   DOI   ScienceOn
9 Stevens, R. D., Hillman, S. L., Worthy, S., Sanders, D. and Millington, D. S. (2000). Assay for Free and Total Carnitine in Human Plasma Using Tandem Mass Spectrometry. Clin. Chem. 46, 727-729
10 Thuillier, L., Rostane, H., Droin, V., Demaugre, F., Brivet, M., Kadhom, N., Prip-Buus, C., Gobin, S., Saudubray, J. M. and Bonnefont, J. P. (2003). Correlation between genotype, metabolic data, and clinical presentation in carnitine palmitoyltransferase 2 (CPT 2) deficiency. Hum. Mutat. 21, 493-501   DOI   ScienceOn
11 Yang, J. Y., Lee, S. J., Park, H. W. and Cha, Y. S. (2006). Effect of genistein with carnitine administration on lipid parameters and obesity in C57Bl/6J mice fed a high-fat diet. J. Med. Food 9, 459-467   DOI   ScienceOn
12 Costa, C. G., Dorland, L., de Almeida, I. T., Jakobs, C., Duran, M. and Poll-The, B. T. (1998). The effect of fasting, long-chain triglyceride load and carnitine load on plasma long-chain acylcarnitine levels in mitochondrial very long-chain acyl-CoA dehydrogenase deficiency. J. Inherit. Metab. Dis. 21, 391-399   DOI   ScienceOn
13 Foster, D. W. (2004). The role of the carnitine system in human metabolism. Ann. N. Y. Acad. Sci. 1033, 1-16   DOI   ScienceOn
14 Hong, Y. M., Kim, H. S. and Yoon, H. R. (2002). Serum lipid and fatty acid profiles in adriamycin-treated rats after administration of L-carnitine. Pediatr. Res. 51, 249-255   DOI   ScienceOn
15 Castro-Chavez, F., Yechoor, V. K., Saha, P. K., Martinez-Botas, J., Wooten, E. C., Sharma, S., O'Connell, P., Taegtmeyer, H. and Chan, L. (2003). Coordinated up regulation of oxidative pathways and down regulation of lipid biosynthesis underlie obesity resistance in perilipin knockout mice: a microarray gene expression profile. Diabetes 52, 2666-2674   DOI   ScienceOn
16 Ronnett, G. V., Kim, E. K., Landree, L. E. and Tu, Y. (2005). Fatty acid metabolism as a target for obesity treatment. Physiol. Behav. 85, 25-35   DOI   ScienceOn
17 Saper, R. B., Eisenberg, D. M. and Phillips, R. S. (2004). Common dietary supplements for weight loss. Am. Fam. Physician 70, 1731-1738
18 Spiekerkotter, U., Schwahn, B., Korall, H., Trefz, F. K., Andresen, B. S. and Wendel, U. (2000). Very-long-chain acyl-coenzyme A dehydrogenase (VLCAD) deficiency: monitoring of treatment by carnitine/acylcarnitine analysis in blood spots. Acta Paediatr. 89, 492-495   DOI
19 Stanley, C. A., Sunaryo, F., Hale, D. E., Bonnefont, J. P., Demaugre, F. and Saudubray, J. M. (1992). Elevated plasma carnitine in the hepatic form of carnitine palmitoyltransferase-1 deficiency. J. Inherit. Metab. Dis. 15, 785-789   DOI
20 Yoon, H. R., Hong, Y. M., Boriack, R. L. and Bennett, M. J. (2003). Effect of L-carnitine supplementation on carnitine palmitoyltransferase activates and plasma carnitine concentrations in adriamycin treated rat. Pediatric. Res. 53, 788-792   DOI   ScienceOn
21 Kuhajda, F. P. and Ronnett, G. V. (2007). Modulation of carnitine palmitoyltransferase-1 for the treatment of obesity. Curr. Opin. Investig. Drugs 8, 312-317
22 Bonnefont, J. P., Djouadi, F., Prip-Buus, C., Gobin, S., Munnich, A. and Bastin, J. (2004). Carnitine palmitoyltransferase 1 and 2: biochemical, molecular and medical aspects. Mol. Aspects Med. 25, 495-520   DOI   ScienceOn
23 Robitaille, J., Houde, A., Lemieux, S., Perusse, L., Gaudet, D. and Vohl, M. C. (2007). Variants within the muscle and liver isoforms of the carnitine palmitoyltransferase I (CPT 1) gene interact with fat intake to modulate indices of obesity in French-Canadians. J. Mol. Med. 85, 129-137   DOI
24 Spiekerkoetter, U., Tokunaga, C., Wendel, U., Mayatepek, E., Exil, V., Duran, M., Wijburg, F. A., Wanders, R. J. and Strauss, A. W. (2004). Changes in blood carnitine and acylcarnitine profiles of very long-chain acyl-CoA dehydrogenase-deficient mice subjected to stress. Eur. J. Clin. Invest. 34, 191-196   DOI   ScienceOn